Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 8/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13649512 | 0.93 | TSHR (0.39) | TSHRACHEALDH1A1CHRM2CHRM4 | |
| SCHEMBL1104746 | 0.82 | — | — | |
| SCHEMBL5620270 | 0.80 | — | — | |
| SCHEMBL5297614 | 0.80 | — | — | |
| SCHEMBL13857470 | 0.80 | — | — | |
| SCHEMBL17550827 | 0.80 | ACHE (0.59) | TSHRACHECHRNB2CHRNA4 | |
| SCHEMBL10050100 | 0.78 | ACHE (0.52) | TSHRACHEALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL24452809 | 0.77 | CHRNB2 (0.50) | TSHRACHEALDH1A1CHRM2CHRM4 | |
| SCHEMBL12846318 | 0.77 | CA12 (0.41) | TSHRACHEALDH1A1CHRNB2NFKB1 | |
| SCHEMBL9587596 | 0.77 | CHRNB2 (0.50) | TSHRACHEALDH1A1CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2112136-B1 | BIS(2-ALKOXYETHYL) AZODICARBOXYLATE ESTER COMPOUND AND INTERMEDIATE FOR PRODUCTION OF THE SAME | TOYO BOSEKI (JP) | 2012-05-23 | — | — | EP | disclosed |
| EP-2112136-B1 | BIS(2-ALKOXYETHYL) AZODICARBOXYLATE ESTER COMPOUND AND INTERMEDIATE FOR PRODUCTION OF THE SAME | TOYO BOSEKI (JP) | 2012-05-23 | — | — | EP | disclosed |
| US-7947816-B2 | Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2011-05-24 | — | — | US | disclosed |
| US-7947816-B2 | Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2011-05-24 | — | — | US | disclosed |
| US-7947816-B2 | Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2011-05-24 | — | — | US | disclosed |
| US-20110028701-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | TOYOBO MC CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20110028701-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | TOYOBO MC CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20110028701-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | TOYOBO MC CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-7820802-B2 | Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof | TOYOBO MC CORPORATION (JP) | 2010-10-26 | — | — | US | disclosed |
| US-7820802-B2 | Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof | TOYOBO MC CORPORATION (JP) | 2010-10-26 | — | — | US | disclosed |
| US-7820802-B2 | Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof | TOYOBO MC CORPORATION (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20100048881-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | TOYO KASEI KOGYO CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100048881-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | TOYO KASEI KOGYO CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100048881-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | TOYO KASEI KOGYO CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-2112136-A1 | BIS(2-ALKOXYETHYL) AZODICARBOXYLATE ESTER COMPOUND AND INTERMEDIATE FOR PRODUCTION OF THE SAME | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2009-10-28 | — | — | EP | disclosed |
| EP-2112136-A1 | BIS(2-ALKOXYETHYL) AZODICARBOXYLATE ESTER COMPOUND AND INTERMEDIATE FOR PRODUCTION OF THE SAME | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2009-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028701-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | CPS1, MCCC2, PC | TSHR 4109/4885ACHE 3542/4885ALDH1A1 554/4885 |
| US-20100048881-A1 | AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF | CPS1, MCCC2, PC | TSHR 4109/4885ACHE 3542/4885ALDH1A1 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.